Saf Health Work.  2010 Sep;1(1):80-86.

A Study of Micronucleus Induction with Methyl Formate and 2-Methylbutane in Bone Marrow Cells of Male ICR Mice

Affiliations
  • 1Center for Chemicals Safety and Health, Occupational Safety and Health Research Institute, KOSHA, Daejeon, Korea. ktrim@kosha.net

Abstract


OBJECTIVES
We investigated the genotoxicity of two chemicals, methyl formate and 2-methylbutane, using male ICR mice bone marrow cells for the screening of micronucleus induction. Although these two chemicals have already been tested numerous times, a micronucleus test has not been conducted and the amounts used have recently been increased.
METHODS
7 week male ICR mice were tested at dosages of 250, 500, and 1,000 mg/kg for methyl formate and 500, 1,000, and 2,000 mg/kg for 2-methlybutane, respectively. After 24 hours of oral administration with the two chemicals, the mice were sacrificed and their bone marrow cells were prepared for smearing slides.
RESULTS
As a result of counting the micronucleated polychromatic erythrocyte (MNPCE) of 2,000 polychromatic erythrocytes, all treated groups expressed no statistically significant increase of MNPCE compared to the negative control group. There were no clinical signs related with the oral exposure of these two chemicals.
CONCLUSION
It was concluded that the two chemicals did not induce micronucleus in the bone marrow cells of ICR mice, and there was no direct proportion with dosage. These results indicate that the two chemicals have no mutagenic potential under each study condition.

Keyword

Mice; Bone marrow; Micronucleus induction; Methyl formate; 2-Methylbutane

MeSH Terms

Administration, Oral
Animals
Bone Marrow
Bone Marrow Cells
Erythrocytes
Formic Acid Esters
Humans
Male
Mass Screening
Mice
Mice, Inbred ICR
Micronucleus Tests
Pentanes
Formic Acid Esters
Pentanes
Full Text Links
  • SHAW
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr